Tecan Group AG (TCHBF)
400.00
0.00 (0.00%)
USD |
OTCM |
May 31, 16:00
Tecan Group Shareholders Equity (Quarterly): 1.606B for Dec. 31, 2023
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 1.606B |
| June 30, 2023 | 1.494B |
| June 30, 2023 | 1.494B |
| December 31, 2022 | 1.464B |
| June 30, 2022 | 1.379B |
| June 30, 2022 | 1.379B |
| December 31, 2021 | 1.340B |
| June 30, 2021 | 889.97M |
| June 30, 2021 | 889.97M |
| December 31, 2020 | 839.73M |
| June 30, 2020 | 710.73M |
| June 30, 2020 | 710.73M |
| December 31, 2019 | 680.20M |
| June 30, 2019 | 627.17M |
| June 30, 2019 | 627.17M |
| December 31, 2018 | 622.02M |
| June 30, 2018 | 573.27M |
| June 30, 2018 | 573.27M |
| December 31, 2017 | 564.75M |
| June 30, 2017 | 526.87M |
| June 30, 2017 | 526.87M |
| Date | Value |
|---|---|
| December 31, 2016 | 479.07M |
| June 30, 2016 | 448.93M |
| June 30, 2016 | 448.93M |
| December 31, 2015 | 445.83M |
| June 30, 2015 | 425.39M |
| June 30, 2015 | 425.39M |
| December 31, 2014 | 365.28M |
| June 30, 2014 | 379.38M |
| June 30, 2014 | 379.38M |
| December 31, 2013 | 378.83M |
| June 30, 2013 | 323.95M |
| June 30, 2013 | 323.95M |
| December 31, 2012 | 321.62M |
| June 30, 2012 | 286.02M |
| June 30, 2012 | 286.02M |
| December 31, 2011 | 284.63M |
| June 30, 2011 | 286.97M |
| December 31, 2010 | 243.96M |
| June 30, 2010 | 168.25M |
| December 31, 2009 | 195.96M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
627.17M
Minimum
Jun 2019
1.606B
Maximum
Dec 2023
1.075B
Average
889.97M
Median
Jun 2021
Shareholders Equity (Quarterly) Benchmarks
| AC Immune SA | 160.35M |
| CRISPR Therapeutics AG | 2.084B |
| Addex Therapeutics Ltd | 1.364M |
| NLS Pharmaceutics Ltd | -8.834M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 2.469B |
| Total Liabilities (Quarterly) | 863.22M |